---
title: "enVVeno Medical Faces Nasdaq Delisting Notice"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/260610505.md"
description: "enVVeno Medical (NVNO) has received a Nasdaq delisting notice due to its stock price falling below the $1.00 minimum bid requirement for 30 consecutive business days. The company has until April 6, 2026, to regain compliance. Spark's AI Analyst rates NVNO as Neutral, citing strong technical performance but significant profitability issues, including negative income and cash flow. The current market cap is $18.43M, with an average trading volume of 954,336."
datetime: "2025-10-10T10:58:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260610505.md)
  - [en](https://longbridge.com/en/news/260610505.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260610505.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/260610505.md) | [English](https://longbridge.com/en/news/260610505.md)


# enVVeno Medical Faces Nasdaq Delisting Notice

enVVeno Medical ( (NVNO) ) has shared an update.

On October 7, 2025, enVVeno Medical Corporation was notified by Nasdaq that its common stock had fallen below the $1.00 per share minimum bid price requirement for 30 consecutive business days, putting it out of compliance with Nasdaq’s listing rules. The company has until April 6, 2026, to regain compliance by ensuring its stock closes at or above $1.00 for at least 10 consecutive trading days. Failure to comply could lead to delisting, though the company may qualify for an additional compliance period and has the right to appeal any delisting decision.

**Spark’s Take on NVNO Stock**

According to Spark, TipRanks’ AI Analyst, NVNO is a Neutral.

enVVeno Medical’s overall stock score is influenced by its robust technical performance, which is somewhat overshadowed by challenging financial metrics. The company faces significant profitability issues, as reflected by its negative income and cash flow figures, despite having a stable balance sheet. While technical indicators show strong upward momentum, valuation concerns due to a negative P/E ratio and lack of dividends weigh on the score.

To see Spark’s full report on NVNO stock, click here.

**More about enVVeno Medical**

**Average Trading Volume:** 954,336

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $18.43M

Find detailed analytics on NVNO stock on TipRanks’ Stock Analysis page.

### 相關股票

- [enVVeno Medical (NVNO.US)](https://longbridge.com/zh-HK/quote/NVNO.US.md)

## 相關資訊與研究

- [How to interpret the wild swings in the jobs numbers](https://longbridge.com/zh-HK/news/281681321.md)
- [Orient Securities Keeps Their Buy Rating on Geely Automobile Holdings (GELYF)](https://longbridge.com/zh-HK/news/281674321.md)
- [Omeros Turns Corner With Novo Deal, YARTEMLEA Launch](https://longbridge.com/zh-HK/news/281666535.md)
- [The High-Bandwidth Memory (HBM) Bottleneck Can Still Cause Micron's Stock to Soar](https://longbridge.com/zh-HK/news/281662827.md)
- [Fitness Stocks To Research - April 3rd](https://longbridge.com/zh-HK/news/281662093.md)